Showing results (2681-2690 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|May 16, 2014
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinomaMasafumi Ikeda, Shuichiro Shiina, Kohei Nakachi, et al.Investigational New Drugs|November 9, 2012
Determinants of patient screen failures in Phase 1 clinical trialsAlexandra Mckane, Chao Sima, Ramesh K Ramanathan, et al.Investigational New Drugs|November 16, 2012
Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanomaTara C Gangadhar, Joseph I Clark, Theodore Karrison, et al.Investigational New Drugs|January 29, 2014
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximabJeeyun Lee, Yong Sang Hong, Jung Yong Hong, et al.Investigational New Drugs|January 1, 1986
Aminoglutethimide. Penetration of the blood brain barrierC Unger, H Eibl, H W von Heyden, et al.Investigational New Drugs|January 1, 1986
Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanomaT A Braich, S E Salmon, A Robertone, et al.Investigational New Drugs|January 1, 1985
Mitoxantrone in refractory acute leukemia in children: a phase I studyK A Starling, A F Mulne, T S Vats, et al.Investigational New Drugs|January 1, 1985
Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysineU Bruntsch, G Groos, T A Hiller, et al.Investigational New Drugs|January 1, 1985
Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot studyR H Earhart, F M Muggia, F M GolombInvestigational New Drugs|January 1, 1985
Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case reportW Scheithauer, H Ludwig, E MaidaPageof 372